AN ECONOMIC EVALUATION OF RANIBIZUMAB VERSUS AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR (WET) AMD IN THE UNITED KINGDOM

被引：1
|
作者：
Malcolm, W. A. [1 ]
Claxton, L. [2 ]
Hodgson, R. [3 ]
Taylor, M. [2 ]
机构：
[1] Novartis UK, Frimley, England
[2] Univ York, York Hlth Econ Consortium, York YO10 5DD, N Yorkshire, England
[3] York Hlth Econ Consortium, York, N Yorkshire, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1057
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS25
引用
收藏
页码：A183 / A183
页数：1
相关论文
共 50 条
  • [21] Intravitreal Injections of Ranibizumab (Lucentis) for Treatment of Wet AMD
    Smirnov, E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [22] Real-World Results of Aflibercept versus Ranibizumab for the Treatment of Exudative AMD Using a Fixed Regimen
    Providencia, Joana
    Rodrigues, Tiago M.
    Oliveira, Mariana
    Bernardes, Joao
    Marques, Joao Pedro
    Murta, Joaquim
    Silva, Rufino
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [23] Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set
    A Lotery
    R Griner
    A Ferreira
    F Milnes
    P Dugel
    Eye, 2017, 31 : 1697 - 1706
  • [24] Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set
    Lotery, A.
    Griner, R.
    Ferreira, A.
    Milnes, F.
    Dugel, P.
    EYE, 2017, 31 (12) : 1697 - 1706
  • [25] Anatomic and functional results with Aflibercept in poor-responders to Ranibizumab with long term recurrent neovascular AMD
    Lima Modino, Laura Andrea
    Pacheco Callirgos, Gabriela Estefania
    Blando Labrandero, Carlos Daniel
    Lopez Galvez, Maria Isabel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [26] Response to Ranibizumab Therapy in Neovascular AMD - An Evaluation of Good and Bad Responders
    Menghini, M.
    Kurz-Levin, M. M.
    Amstutz, C.
    Michels, S.
    Windisch, R.
    Barthelmes, D.
    Sutter, F. Kp.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2010, 227 (04) : 244 - 248
  • [27] United Kingdom Neovascular AMD Database study: Time to reactivation after a pause in treatment - outcomes from 92,000 intravitreal ranibizumab injections
    Keane, Pearse Andrew
    McKibbin, Martin
    Lee, Aaron Y.
    Chakravarthy, Usha
    Johnston, Robert
    Egan, Catherine A.
    Sim, Dawn A.
    Zarranz-Ventura, Javier
    Tufail, Adnan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [28] Comments to: Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD
    Calugaru, Dan
    Calugaru, Mihai
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (05) : E138 - E138
  • [29] Lentiviral delivered aflibercept OXB-203 for treatment of neovascular AMD
    Iqball, Sharifah
    Beck, Daniel K.
    Devarajan, Gayathri
    Khoo, Cheen P.
    OConnor, Deirdre M.
    Ellis, Scott
    Guzman, Efrain
    Mitrophanous, Kyriacos A.
    Lad, Yatish
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2023, 30 : 350 - 366
  • [30] Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results
    Cardoso, Pedro Neves
    Pinheiro, Ana Fernanda
    Meira, Jorge
    Pedrosa, Ana Catarina
    Falcao, Manuel S.
    Pinheiro-Costa, Joao
    Falcao-Reis, Fernando
    Carneiro, Angela M.
    JOURNAL OF OPHTHALMOLOGY, 2017, 2017
12345